2011 Press Release

RSS

Press Release

12.26.2011 Santen to Retire Treasury Stock [PDF:17KB]

12.26.2011 Santen's Noto Plant Obtains Certification of ISO 14001 [PDF:17KB]

12.26.2011 Implementation of a squeeze-out on the shares of Novagali Pharma SA initiated by Santen Pharmaceutical Co., Ltd.

12.26.2011 Mise en œuvre par Santen Pharmaceutical Co., Ltd. de la procédure de retrait obligatoire portant sur les actions de Novagali Pharma SA

12.26.2011 Notice on Board of Directors

12.26.2011 Santen to Issue Stock Acquisition Rights for the Purpose of Granting Stock Options [PDF:20KB]

12.22.2011 Succès de l'offre publique d'achat simplifiée de Santen Pharmaceutical Co., Ltd. sur les actions et les bons desouscription d'actions de Novagali Pharma SA

12.22.2011 Notice of a successful result of the Simplified Cash Tender Offer for the Shares and bons de souscription d'actions of Novagali Pharma SA by Santen Pharmaceutical Co., Ltd.

12.10.2011 Santen Pharmaceutical Co., Ltd. completes the acquisition of a controlling interest in Novagali Pharma S.A.

12.01.2011 Ouverture de l'offre publique d'achat simplifiée

12.01.2011 Informations Relatives aux Caractéristiques, Notamment Juridiques, Financieres et Comptables de la Societe Santen Pharmaceutical Co., Ltd.

12.01.2011 Mise à disposition de la note d'information relative à l'offre publique d'achat simplifiée sur Novagali Pharma SA et des informations relatives aux caractéristiques notamment juridiques, financières et comptables de Santen Pharmaceutical Co., Ltd.

12.01.2011 The Offer Document relating to the Simplified Cash Tender Offer for the Shares and Warrants of Novagali Pharma S.A. by Santen Pharmaceutical Co., Ltd.

11.30.2011 Note d'information de la societe Santen Pharmaceutical Co., Ltd.

11.10.2011 Dépôt d'une offre publique d'achat simplifiée

11.10.2011 Filing of a Draft Simplified Cash Tender Offer regarding Novagali Pharma SA

11.10.2011 Offer Publique D'achat Simplifyée

11.01.2011 Santen Announces Financial Result for the Second Quarter ended September 30, 2011

10.14.2011 Ube and Santen Announce License and Collaboration Agreement for EP2 Agonist

10.05.2011 Announcement of the Year-end Dividends

10.05.2011 Medium Term Management Plan FY2011-2013

10.05.2011 Santen to Issue Rights to Subscribe for New Shares as Stock Options in favor of Directors

10.05.2011 Santen to Issue Rights to Subscribe for New Shares as Stock Options in favor of Corporate Officers

10.05.2011 Notice of the Nominations for the Member of the Board

09.28.2011 Signing of an agreement with respect to an acquisition of a controlling interest in Novagali Pharma S.A. by Santen Pharmaceutical Co., Ltd.

08.02.2011 Notice on the Establishment of Subsidiary in India

08.02.2011 Santen Announces Financial Result for the First Quarter ended June 30, 2011

07.05.2011 Notice on the Exercise Price of Stock Options (Stock Acquisition Rights)

06.22.2011 Notice on the Allotment of Stock Options (Stock Acquisition Rights)

06.02.2011 Santen Launches Broad-spectrum Antibacterial Ophthalmic Solution Cravit Ophthalmic Solution 1.5%

05.10.2011 Santen Announces Financial Results for the Year ended March 31, 2011

04.21.2011 Announcement regarding Recall of OTC Eye Drop Product

04.14.2011 Santen Inc. Head Office Relocation

03.23.2011 Notice of the change of Corporate Officer

03.17.2011 Effect of the Tohoku-Kanto Earthquake on Santen

03.15.2011 Notice of Donation with regards to the Tohoku-Kanto Earthquake

03.10.2011 Notice of the appointment of Corporate Officers

02.14.2011 Notice Concerning Changes in Status of Major Shareholders After Disposal of Treasury Stock Through Third-Party Allotment

02.08.2011 Notice Concerning Execution of Business and Capital Alliance Agreement and Disposal of Treasury Stock Through Third-Party Allotment

02.08.2011 Santen Announces Financial Result for the Third Quarter ended December 31, 2010

Official SNS

YouTube

Copyright © 2023 Santen Pharmaceutical Co., Ltd.
All Rights Reserved